Dose Escalation Safety Study of Brentuximab Vedotin for Diffuse Cutaneous Systemic Sclerosis:Clinical Results and Mechanistic Analysis of Skin and Peripheral Blood Mononuclear Cells

被引：0

作者：

Fox, David ^{[1
]}

Cooney, Laura ^{[2
,3
]}

Stelzig, Lia ^{[4
]}

Lafyatis, Robert ^{[5
]}

Gudjonsson, Johann ^{[6
]}

Tsoi, Lam ^{[2
]}

Mayes, Maureen ^{[7
]}

Shah, Ankoor ^{[8
]}

Kafaja, Suzanne ^{[9
]}

Barry, William ^{[4
]}

Goldmuntz, Ellen ^{[10
]}

Smilek, Dawn

Khanna, Dinesh ^{[2
,11
]}

机构：

[1] Univ Michigan, Dexter, MI USA

[2] Univ Michigan, Ann Arbor, MI USA

[3] Immune Tolerance Network, Ann Arbor, MI USA

[4] Rho, Durham, NC USA

[5] Univ Pittsburgh, Div Rheumatol & Clin Immunol, Pittsburgh, PA USA

[6] Univ Michigan, Dept Dermatol, Ann Arbor, MI USA

[7] UTHlth Houston, Div Rheumatol, Houston, TX USA

[8] Duke Univ, Durham, NC USA

[9] Univ Calif Los Angeles, Div Rheumatol, Los Angeles, CA USA

[10] NIAID, Div Allergy Immunol & Transplantat, Rockville, MD USA

[11] UCSF, Immune Tolerance Network, San Francisco, CA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2686

引用

页码：5445 / 5447

页数：3